Picture of BBS-Bioactive Bone Substitutes Oyj logo

BONEH — BBS-Bioactive Bone Substitutes Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bioactive Bone Substitutes Oyj Informed By Notified Body That Final Approval Of Quality System Is Expected Within Approximately One Month

Nov 2 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
 BONEH.HE :
    * BBS-BIOACTIVE BONE SUBSTITUTES OYJ - INFORMED BY NOTIFIED
BODY
THAT FINAL APPROVAL OF QUALITY SYSTEM IS EXPECTED WITHIN
APPROXIMATELY ONE MONTH
    * BBS-BIOACTIVE BONE SUBSTITUTES OYJ - CO'S GUIDANCE ON
OVERALL
SCHEDULE FOR CE MARKING REMAINS UNCHANGED
    * BBS-BIOACTIVE BONE SUBSTITUTES - FOLLOWING QUALITY SYSTEM
APPROVAL, PRODUCT APPROVAL IS NEXT, PART OF WHICH IS
CONSULTATION WITH FINNISH MEDICINES AGENCY
    * BBS-BIOACTIVE BONE SUBSTITUTES - CONSULTATION WITH FIMEA
IS PART
OF OFFICIAL CE MARKING PROCESS ;CO EXPECTS CONSULTATION TO TAKE
3-7 MONTHS TO BE COMPLETED
    * BBS-BIOACTIVE BONE SUBSTITUTES OYJ - NOTIFIED BODY HAS
INFORMED
COMPANY ON 2 NOVEMBER 2023 THAT CONSULTATION WILL BEGIN ON 21
NOVEMBER 2023

Source text for Eikon:  ID:nGNE5ymPG4 
Further company coverage:  BONEH.HE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BBS-Bioactive Bone Substitutes Oyj

See all news